#Polyethylene glycol #Polyethylene glycol (peg) is a polymer with the lowest level of protein and cell absorption, which has moisturizing, adhesion, lubricity, biocompatibility and other properties, and is non-toxic and non-irritating to the human body, so it is used in daily chemicals, medicine, pesticides, plastics, papermaking, paints, cosmetics and other fields. In addition, polyethylene glycol can also be used as a film coating agent, tablet lubricant, etc. In the field of medicine, it can be used as an ophthalmic preparation, oral and rectal preparation. In addition, polyethylene glycol as a polymer material with the best biocompatibility, the application of medical machinery is also being developed, so the application prospect of polyethylene glycol in the future is better.
Although polyethylene glycol is widely used, it has higher application requirements in medical treatment, in addition to higher molecular weight requirements, it also has high standards for purity, dispersibility and impurity content. Limited by production technology, China's polyethylene glycol is difficult to meet the standard of pharmaceutical raw materials for injection, so China's high-end medical polyethylene glycol raw materials have been imported for a long time, and the market substitution space in the future high-end medical field is large.
According to the "2020-2024 China Polyethylene Glycol Drug Industry Comprehensive Market Research and Investment Analysis Report" released by the New Thought Industry Research Center, in the world, the application research on polyethylene glycol in medical treatment has been deepening, and in recent years, there have been breakthroughs, which can be used in the field of drugs for protein/peptide drug coupling, small molecule drugs, nucleotides and other coupling drugs. In addition, polyethylene glycol can also be used for tissue isolation, vascular sealing, etc. Affected by the rapid development of Biomedical Technology in China, China's polyethylene glycol drug industry has developed rapidly, and by the end of 2019, China has approved more than 5 polyethylene glycol modified drugs for listing.
In the research of polyethylene glycol medical devices, there are currently a number of products on the market, such as Medtronic, cardinalhealth, Boston Scientific, Baxter and other companies to study products. China's research on polyethylene glycol medical devices is still in its infancy, there are no products on the market, the products developed by KeyKai Technology are still in the clinic, but in view of the wide application of polyethylene glycol medical devices in overseas markets, it is expected that the development prospects of China's polyethylene glycol medical device industry in the next few years are better. At present, polyethylene glycol that is used in medical device products is mostly polyethylene glycol derivatives of multi-armed polyethylene glycol, and gel medical devices produced by such products can be widely used in radiotherapy and surgery, so the research and development prospects are better.
New Thinking industry analysts said that polyethylene glycol is widely used in medicine, and the research and development value is high, and the industry development prospects are better. However, due to the high technical threshold for the application of polyethylene glycol in medicine and medical devices, there are fewer currently applied products, and the future market development potential is greater. In terms of polyethylene glycol raw materials, limited by production technology, China's medical grade polyethylene glycol market demand is still dependent on imports, and the future domestic replacement space is large.